Assault by drugs, medicaments and biological substances

VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — X85 Cause of death: ICD-10 — X85 2 out of 7 registries used, show all original rules.	62
4. Check minimum number of events None	62
5. Include endpoints None	62
6. Filter based on genotype QC (FinnGen only)	54

Control definitions (FinnGen only)

Control exclude: VWXY20_ASSAULT

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: X85-Y09

NAME	VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST
CONTROL_EXCLUDE	VWXY20_ASSAULT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	X85
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	X85
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Assault by drugs, medicaments and biological substances based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	54	28	26
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	38.02	39.33	36.59

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
59: Matched controls
590

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

X85.9

ICD-10 Finland

Assault by drugs, medicaments and biological substances by unknown person

+∞

47.4

T74.1

ICD-10 Finland

Physical abuse

84.3

16.9

F32.9

ICD-10 Finland

Depressive episode, unspecified

9.4

14.5

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

16.4

12.9

X85.0

ICD-10 Finland

Assault by drugs, medicaments and biological substances by spouse or partner

+∞

11.8

T36

ICD-10 Finland

Poisoning by systemic antibiotics

21.1

11.7

Y09

ICD-10 Finland

Assault by unspecified means

+∞

10.7

S06.0

ICD-10 Finland

Concussion

8.6

8.9

Y07

ICD-10 Finland

Other maltreatment

+∞

8.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

4.6

7.7

103

P15

ICPC

Chronic alcohol abuse

18.9

7.6

N05BA01

ATC

diazepam; systemic, rectal

5.6

7.3

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

16.5

7.2

N05AH04

ATC

quetiapine; oral

4.5

7.1

SPAT1263

SPAT

Sampling

4.0

6.5

157

N06AB06

ATC

sertraline; oral

5.1

6.4

Y04.8

ICD-10 Finland

Assault by bodily force by other known person

+∞

6.4

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

+∞

6.4

N05BA04

ATC

oxazepam; oral

4.0

6.2

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

7.1

6.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(1001926) Buprenorphine [Presence] in Urine by Screen method

7.35

6.36

3.1

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

14.85

5.79

1.0

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

5.73

5.34

3.3

1.3

0.29

0.14

mg/l

—

(3028707) Methadone [Presence] in Urine by Screen method

8.17

5.23

3.4

1.1

—

(3016879) Cocaine [Presence] in Urine

5.55

5.21

3.1

1.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

6.35

5.14

4.3

1.3

—

(3032080) INR in Blood by Coagulation assay

184

3.45

5.11

11.8

10.1

1.14

1.13

inr

0.05

152

(3000764) Benzodiazepines [Presence] in Urine

5.07

4.85

3.1

1.2

—

(3027008) Opiates [Presence] in Urine

4.93

4.74

3.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

4.93

4.74

3.1

1.2

—

(3027944) Amphetamines [Presence] in Urine

4.80

4.62

3.1

1.2

—

(3042936) Bacteria identified in Isolate by Culture

3.35

3.68

1.9

2.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

109

2.82

3.43

3.8

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

227

2.50

2.90

4.1

2.6

—

estimate

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

227

2.50

2.90

8.6

7.6

1.18

1.21

mmol/l

2.00

199

(3023368) Bacteria identified in Blood by Culture

113

2.51

2.72

6.0

4.2

—

(3026008) Bacteria identified in Urine by Culture

114

2.48

2.66

3.2

2.3

—

(3044640) Blood type and Crossmatch panel - Blood

154

2.39

2.65

3.9

2.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

7.66

2.60

2.6

1.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3.13

2.27

2.4

3.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

3.82

2.13

1.1

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.39

2.10

2.1

1.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

3.80

1.89

1.8

1.5

—

(40768797) Stomach Pathology biopsy report

2.39

1.89

1.1

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.22

1.84

8.1

3.8

389.20

437.23

ng/l

—

(3030467) Casts [#/volume] in Urine by Automated count

135

2.00

1.67

2.7

2.4

0.36

0.16

e6/l

0.24

100

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3.80

1.65

8.4

1.5

—

(36304419) Bacteria [Presence] in Urine

136

1.98

1.63

2.2

2.3

—

estimate

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.20

1.60

4.1

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

137

1.97

1.60

2.5

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3.54

1.55

4.4

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2.17

1.55

1.6

1.9

28.03

29.08

0.43

(40768804) Tissue Pathology biopsy report

202

1.86

1.49

2.5

1.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.92

1.47

3.0

4.5

26.40

24.01

mmol/l

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

3.31

1.47

1.6

2.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.60

1.44

4.9

4.2

132.86

126.93

g/l

—

(40758558) Short blood count panel - Blood

150

1.87

1.44

6.9

—

(3015736) pH of Urine

223

1.82

1.42

4.8

2.9

6.15

6.09

0.14

133

(3007853) Bacteria identified in Skin by Aerobe culture

2.10

1.29

2.3

1.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

129

1.83

1.27

2.4

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.78

1.24

1.2

1.8

—

(3022145) Colonoscopy Study observation

2.16

1.19

1.4

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.63

1.17

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.85

1.10

3.5

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.99

1.07

2.8

7.3

1.04

1.02

mmol/l

0.07

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

111

1.75

1.02

2.2

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

184

1.62

0.97

3.0

2.0

83.21

102.00

pmol/l

1.86

100

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.27

0.94

1.7

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2.19

0.92

1.3

66.42

67.65

g/l

—

(3025941) Bacteria identified in Stool by Culture

2.19

0.92

2.2

1.2

—

(3012544) pH of Venous blood

1.90

0.88

4.6

3.6

7.34

7.39

—

(3037467) Urinalysis macro (dipstick) panel - Urine

345

1.62

0.88

5.7

3.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

179

1.57

0.86

4.5

3.0

30.04

26.99

ng/l

0.06

102

(3002582) Erythrocytes [#/volume] in Urine

161

1.58

0.85

2.9

2.5

10.91

24.95

e6/l

0.73

127

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.71

0.85

1.5

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.73

0.83

3.5

2.2

—

(3000494) Fungus identified in Specimen by Culture

1.78

0.79

2.2

1.4

—

(3019150) Specific gravity of Urine by Refractometry

119

1.60

0.78

6.9

3.0

1.02

kg/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.80

0.78

2.1

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.71

0.77

3.0

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.01

0.72

1.4

1.3

—

(4035726) Immunohistochemistry procedure

1.75

0.71

1.4

1.3

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.74

0.70

3.5

7.4

103.40

104.11

mmol/l

—

(40761535) Cells panel - Urine sediment

1.79

0.65

2.4

3.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

170

1.47

0.65

2.8

2.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

107

1.54

0.63

1.4

1.3

1.22

3.82

u/ml

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.61

0.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.59

0.61

2.1

1.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

0.00

0.61

0.0

3.6

—

1.37

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.59

0.58

3.2

1.6

—

(3019198) Lymphocytes [#/volume] in Blood

291

1.40

0.55

9.0

6.9

2.00

1.82

e9/l

0.55

269

(3041096) Erythrocytes [Presence] in Urine by Automated

156

1.43

0.55

3.0

2.5

0.00

0.02

estimate

—

(42870588) Differential panel, method unspecified - Blood

185

1.40

0.53

10.5

6.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1.55

0.50

3.3

3.6

6.09

5.52

kpa

—

(3019060) Gas panel - Arterial blood

1.67

0.44

13.2

7.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

0.00

0.42

0.0

1.1

—

0.16

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.51

0.41

1.2

2.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.45

0.41

1.6

1.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

211

1.32

0.41

5.0

2.9

0.00

estimate

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.41

0.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.86

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.41

0.0

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.41

0.0

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

4.19

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

195

1.29

0.36

6.9

3.7

32.52

29.80

u/l

0.36

188

(3013512) EKG study

131

1.30

0.31

3.6

2.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

419

0.80

0.28

3.3

3.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.31

0.27

1.9

1.4

—

(3029937) Albumin [Presence] in Urine by Test strip

144

1.25

0.26

6.4

3.1

0.00

estimate

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

0.74

0.24

3.7

2.1

0.52

0.68

ug/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

123

0.77

0.23

8.1

3.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

1.27

0.23

4.2

2.8

4.64

4.92

kpa

—

(40761536) Microorganisms panel - Urine sediment

1.27

0.23

3.4

3.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.24

0.22

6.2

5.2

2.84

4.16

ug/l

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.6

—

64.02

—

(3035715) Granulocytes [#/volume] in Blood

0.00

0.21

0.0

3.3

—

3.52

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.31

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(3035933) Granulocytes/Leukocytes in Blood

0.00

0.21

0.0

3.2

—

57.95

—

(3007164) IgA [Mass/volume] in Serum or Plasma

138

1.22

0.20

1.4

1.5

1.92

2.41

g/l

—

(3002256) Pathology report gross observation

1.19

0.18

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

242

0.86

0.17

3.3

2.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

242

1.13

0.12

3.3

3.5

89.86

109.13

ug/l

0.33

233

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

146

0.86

0.12

5.5

3.5

1.45

1.48

ug/l

0.04

133

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1.18

0.10

1.4

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.18

0.10

1.4

2.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

274

1.11

0.10

5.2

3.1

0.00

estimate

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.06

0.09

2.2

320.33

385.59

nmol/l

—

(3003694) ABO and Rh group [Type] in Blood

153

0.89

0.08

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

279

1.08

0.05

5.3

3.1

0.00

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

279

1.08

0.05

5.2

3.1

0.00

estimate

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.10

0.03

3.4

2.5

0.80

0.83

mmol/l

—

(3012516) Albumin [Mass/volume] in Urine

145

1.05

0.00

3.1

3.6

4.86

63.54

mg/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

145

1.05

0.00

2.1

5.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

484

0.96

0.00

28.7

16.2

333.31

333.47

g/l

0.04

484

(3020682) Albumin/Creatinine [Ratio] in Urine

148

1.02

0.00

3.9

4.1

1.09

7.89

mg/mmol

—

(3000492) Spirometry study

0.93

0.00

1.2

1.4

—

(36660697) Celiac disease serology panel - Serum

0.93

0.00

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

32.67

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

2.2

—

1178.00

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

-0.00

0.0

2.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

-0.00

0.0

1.4

—

21.09

—

(3004809) Band form neutrophils/Leukocytes in Blood

0.00

-0.00

0.0

2.1

—

4.00

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

3.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

116.20

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.2

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.8

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

4.34

—

(3005570) Glucose [Moles/volume] in Urine

0.00

-0.00

0.0

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

-0.00

0.0

1.0

—

0.19

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

8.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

0.00

-0.00

0.0

1.6

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.6

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.8

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.8

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

-0.00

0.0

1.0

—

(21494755) Public health laboratory ask at order entry panel

0.97

-0.00

1.1

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

50.54

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

-0.00

0.0

2.0

—

102.00

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

6.3

—

83.43

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

3.3

—

9.93

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

-0.00

0.0

2.0

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

-0.00

0.0

2.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.8

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.02

-0.00

8.4

8.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

76.80

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

2.11

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST – Assault by drugs, medicaments and biological substances

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Assault by drugs, medicaments and biological substances

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Assault by drugs, medicaments and biological substances (VWXY20_ASSAU_DRUGS_MEDICAM_BIOLO_SUBST)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints